Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.
Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.
Sample of Keynote Speakers and their Case Studies
Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.
Discussion on how Eisai evolved its procurement function to become integrated into the business, its subsequent evolution into a digital team, and where would we go next.
Making Procurement an integral part of company strategy through Business Partnership.
Procurement is ready for its next transformation, and whilst AI is considered the holy grail, I will be advocating for the advent of a new era where values-led procurement is the key to a golden procurement future.
How to co-design new sourcing strategies and service solutions leveraging your internal and external community in a digital ecosystem?
Associate Director of Global Capital Procurement – Equipment & Automation Lead
Introduction of Total Cost of Ownership in the context of pharmaceutical capital projects. From the concept to the implementation of TCO, what are the procurement strategies to ensure successful projects and cost optimisation in a very regulated context and changing environment? I will introduce the Cost components to conduct effective TCO and strategies to overcome challenges (accurate data, stakeholder engagement, etc.) and unlock value during the Pharma Capital project and asset life cycle.
How to co-design new sourcing strategies and service solutions leveraging your internal and external community in a digital ecosystem?
Making Procurement an integral part of company strategy through Business Partnership.
Associate Director of Global Capital Procurement – Equipment & Automation Lead
Introduction of Total Cost of Ownership in the context of pharmaceutical capital projects. From the concept to the implementation of TCO, what are the procurement strategies to ensure successful projects and cost optimisation in a very regulated context and changing environment? I will introduce the Cost components to conduct effective TCO and strategies to overcome challenges (accurate data, stakeholder engagement, etc.) and unlock value during the Pharma Capital project and asset life cycle.
Procurement is ready for its next transformation, and whilst AI is considered the holy grail, I will be advocating for the advent of a new era where values-led procurement is the key to a golden procurement future.
Discussion on how Eisai evolved its procurement function to become integrated into the business, its subsequent evolution into a digital team, and where would we go next.
How to co-design new sourcing strategies and service solutions leveraging your internal and external community in a digital ecosystem?
Making Procurement an integral part of company strategy through Business Partnership.
Procurement is ready for its next transformation, and whilst AI is considered the holy grail, I will be advocating for the advent of a new era where values-led procurement is the key to a golden procurement future.
Discussion on how Eisai evolved its procurement function to become integrated into the business, its subsequent evolution into a digital team, and where would we go next.
Associate Director of Global Capital Procurement – Equipment & Automation Lead
Introduction of Total Cost of Ownership in the context of pharmaceutical capital projects. From the concept to the implementation of TCO, what are the procurement strategies to ensure successful projects and cost optimisation in a very regulated context and changing environment? I will introduce the Cost components to conduct effective TCO and strategies to overcome challenges (accurate data, stakeholder engagement, etc.) and unlock value during the Pharma Capital project and asset life cycle.